Nature Reviews Cancer, ISSN 1474-175X, 05/2015, Volume 15, Issue 6, pp. 347 - 360
The eradication of cancer remains a vexing problem despite recent advances in our understanding of the molecular basis of neoplasia. One therapeutic approach...
PHASE-II TRIAL | B-CELL LYMPHOMA | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY | NON-HODGKIN-LYMPHOMA | TARGETED ALPHA-THERAPY | ACUTE MYELOID-LEUKEMIA | STREPTAVIDIN FUSION PROTEIN | MONOCLONAL-ANTIBODY 81C6 | UNTREATED FOLLICULAR LYMPHOMA | Hematologic Neoplasms - radiotherapy | Actinium - administration & dosage | Antibodies, Monoclonal - administration & dosage | Actinium - therapeutic use | Antibodies, Monoclonal - pharmacology | Humans | Radioimmunotherapy - methods | Neoplasms - radiotherapy | Clinical Trials as Topic | Alpha Particles - therapeutic use | Molecular Targeted Therapy - methods | Care and treatment | Research | Health aspects | Radioimmunotherapy | Tumors
PHASE-II TRIAL | B-CELL LYMPHOMA | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | IBRITUMOMAB TIUXETAN RADIOIMMUNOTHERAPY | NON-HODGKIN-LYMPHOMA | TARGETED ALPHA-THERAPY | ACUTE MYELOID-LEUKEMIA | STREPTAVIDIN FUSION PROTEIN | MONOCLONAL-ANTIBODY 81C6 | UNTREATED FOLLICULAR LYMPHOMA | Hematologic Neoplasms - radiotherapy | Actinium - administration & dosage | Antibodies, Monoclonal - administration & dosage | Actinium - therapeutic use | Antibodies, Monoclonal - pharmacology | Humans | Radioimmunotherapy - methods | Neoplasms - radiotherapy | Clinical Trials as Topic | Alpha Particles - therapeutic use | Molecular Targeted Therapy - methods | Care and treatment | Research | Health aspects | Radioimmunotherapy | Tumors
Journal Article
Archives of Pathology and Laboratory Medicine, ISSN 0003-9985, 05/2011, Volume 135, Issue 5, pp. 569 - 577
Context.-Thyroid cancer is the most common type of endocrine malignancy and its incidence is steadily increasing. Papillary carcinoma and follicular carcinoma...
MEDICINE, RESEARCH & EXPERIMENTAL | BRAF V600E MUTATION | N-RAS MUTATION | PATHOLOGY | RET/PTC GENE REARRANGEMENTS | PAPILLARY CARCINOMAS | ONCOGENE ACTIVATION | BRAF(V600E) MUTATION | PAX8-PPAR-GAMMA REARRANGEMENT | NEEDLE-ASPIRATION DIAGNOSIS | CLINICAL-IMPLICATIONS | FOLLICULAR VARIANT | MEDICAL LABORATORY TECHNOLOGY | Thyroid Neoplasms - diagnosis | Carcinoma, Papillary - genetics | Molecular Diagnostic Techniques - methods | Prognosis | Thyroid Neoplasms - mortality | Adenocarcinoma, Follicular - diagnosis | Humans | Adenocarcinoma, Follicular - genetics | Adenocarcinoma, Follicular - mortality | Survival Rate | Neoplasm Recurrence, Local - diagnosis | PubMed | Carcinoma, Papillary - mortality | Point Mutation | Thyroid Neoplasms - genetics | Proto-Oncogene Proteins B-raf - genetics | Chromosome Aberrations | Neoplasm Recurrence, Local - genetics | Carcinoma, Papillary - diagnosis | Gene mutations | Thyroid cancer | Tumors
MEDICINE, RESEARCH & EXPERIMENTAL | BRAF V600E MUTATION | N-RAS MUTATION | PATHOLOGY | RET/PTC GENE REARRANGEMENTS | PAPILLARY CARCINOMAS | ONCOGENE ACTIVATION | BRAF(V600E) MUTATION | PAX8-PPAR-GAMMA REARRANGEMENT | NEEDLE-ASPIRATION DIAGNOSIS | CLINICAL-IMPLICATIONS | FOLLICULAR VARIANT | MEDICAL LABORATORY TECHNOLOGY | Thyroid Neoplasms - diagnosis | Carcinoma, Papillary - genetics | Molecular Diagnostic Techniques - methods | Prognosis | Thyroid Neoplasms - mortality | Adenocarcinoma, Follicular - diagnosis | Humans | Adenocarcinoma, Follicular - genetics | Adenocarcinoma, Follicular - mortality | Survival Rate | Neoplasm Recurrence, Local - diagnosis | PubMed | Carcinoma, Papillary - mortality | Point Mutation | Thyroid Neoplasms - genetics | Proto-Oncogene Proteins B-raf - genetics | Chromosome Aberrations | Neoplasm Recurrence, Local - genetics | Carcinoma, Papillary - diagnosis | Gene mutations | Thyroid cancer | Tumors
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 08/2004, Volume 28, Issue 8, pp. 988 - 998
While tumors of dendritic cell lineage may have overlapping histomorphologic features, most but not all cases can be classified using an immunohistochemical...
Immunohistochemistry | Follicular dendritic cell tumor | Interdigitating dendritic cell tumor | Langerhans cell histiocytosis | Clusterin | SURGERY | clusterin | ENTITY | interdigitating dendritic cell tumor | LYMPH-NODES | SARCOMA | RETICULUM CELLS | follicular dendritic cell tumor | immunohistochemistry | PATHOLOGY | CANCER | Dendritic Cells, Follicular - ultrastructure | Lymph Nodes - pathology | Molecular Chaperones - metabolism | Dendritic Cells, Follicular - metabolism | Cell Count | Humans | Middle Aged | Glycoproteins - metabolism | Male | Combined Modality Therapy | Neoplasm Proteins - metabolism | Sarcoma - pathology | Sarcoma - therapy | Histiocytosis, Langerhans-Cell - metabolism | Sarcoma - metabolism | Histiocytosis, Langerhans-Cell - pathology | Adolescent | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Aged
Immunohistochemistry | Follicular dendritic cell tumor | Interdigitating dendritic cell tumor | Langerhans cell histiocytosis | Clusterin | SURGERY | clusterin | ENTITY | interdigitating dendritic cell tumor | LYMPH-NODES | SARCOMA | RETICULUM CELLS | follicular dendritic cell tumor | immunohistochemistry | PATHOLOGY | CANCER | Dendritic Cells, Follicular - ultrastructure | Lymph Nodes - pathology | Molecular Chaperones - metabolism | Dendritic Cells, Follicular - metabolism | Cell Count | Humans | Middle Aged | Glycoproteins - metabolism | Male | Combined Modality Therapy | Neoplasm Proteins - metabolism | Sarcoma - pathology | Sarcoma - therapy | Histiocytosis, Langerhans-Cell - metabolism | Sarcoma - metabolism | Histiocytosis, Langerhans-Cell - pathology | Adolescent | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Aged
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 07/2017, Volume 14, Issue 7, pp. 399 - 416
Macrophages are crucial drivers of tumour-promoting inflammation. Tumour-associated macrophages (TAMs) contribute to tumour progression at different levels: by...
CHEMOKINE LIGAND 2 | COLONY-STIMULATING FACTOR | T-CELL IMMUNITY | ONCOLOGY | BREAST-CANCER METASTASIS | PANCREATIC-CANCER | HUMAN MONOCLONAL-ANTIBODY | FOLLICULAR LYMPHOMA | CARLUMAB CNTO 888 | MYELOID CELLS | INFILTRATING MACROPHAGES | Neoplasms - therapy | Macrophage Activation - immunology | Neoplasms - immunology | Humans | Antineoplastic Agents - pharmacology | Macrophages - immunology | Molecular Targeted Therapy - methods | Care and treatment | Patient outcomes | Cellular therapy | Macrophages | Health aspects | Methods | Cancer | Cell survival | Lymphocytes T | Adaptive immunity | Radiation therapy | Synergism | Metastases | Genomic instability | Chemotherapy | Cell activation | Reviews | Immune checkpoint | Immunotherapy | Stem cells | Monoclonal antibodies | Phagocytosis | Tumors
CHEMOKINE LIGAND 2 | COLONY-STIMULATING FACTOR | T-CELL IMMUNITY | ONCOLOGY | BREAST-CANCER METASTASIS | PANCREATIC-CANCER | HUMAN MONOCLONAL-ANTIBODY | FOLLICULAR LYMPHOMA | CARLUMAB CNTO 888 | MYELOID CELLS | INFILTRATING MACROPHAGES | Neoplasms - therapy | Macrophage Activation - immunology | Neoplasms - immunology | Humans | Antineoplastic Agents - pharmacology | Macrophages - immunology | Molecular Targeted Therapy - methods | Care and treatment | Patient outcomes | Cellular therapy | Macrophages | Health aspects | Methods | Cancer | Cell survival | Lymphocytes T | Adaptive immunity | Radiation therapy | Synergism | Metastases | Genomic instability | Chemotherapy | Cell activation | Reviews | Immune checkpoint | Immunotherapy | Stem cells | Monoclonal antibodies | Phagocytosis | Tumors
Journal Article
American Journal of Pathology, ISSN 0002-9440, 02/2003, Volume 162, Issue 2, pp. 645 - 654
Ghrelin, a growth hormone-releasing hormone produced by gastroenteropancreatic endocrine cells, hypothalamus, and pituitary, was recently identified in...
ACYLATED PEPTIDE | HORMONE SECRETAGOGUES | PITUITARY | HUMANS | SECRETION | PATHOLOGY | BINDING-SITES | RECEPTORS | STOMACH | Immunohistochemistry | Adenocarcinoma, Follicular - pathology | Humans | Adenocarcinoma, Follicular - genetics | Infant | Peptide Hormones - genetics | Reverse Transcriptase Polymerase Chain Reaction | Gestational Age | Cell Division - physiology | Pregnancy | Thyroid Neoplasms - genetics | Gene Expression Regulation, Developmental | Ghrelin | Adult | Female | Thyroid Gland - embryology | Thyroid Gland - growth & development | Peptide Hormones - analysis | Tumor Cells, Cultured | Child | Thyroid Neoplasms - pathology | Regular
ACYLATED PEPTIDE | HORMONE SECRETAGOGUES | PITUITARY | HUMANS | SECRETION | PATHOLOGY | BINDING-SITES | RECEPTORS | STOMACH | Immunohistochemistry | Adenocarcinoma, Follicular - pathology | Humans | Adenocarcinoma, Follicular - genetics | Infant | Peptide Hormones - genetics | Reverse Transcriptase Polymerase Chain Reaction | Gestational Age | Cell Division - physiology | Pregnancy | Thyroid Neoplasms - genetics | Gene Expression Regulation, Developmental | Ghrelin | Adult | Female | Thyroid Gland - embryology | Thyroid Gland - growth & development | Peptide Hormones - analysis | Tumor Cells, Cultured | Child | Thyroid Neoplasms - pathology | Regular
Journal Article
Modern Pathology, ISSN 0893-3952, 2011, Volume 24, Issue 2, pp. S34 - S43
In the recent years, a large number of molecular alterations in thyroid cancer has been discovered and characterized. Some of these markers may have...
RET/PTC | BRAF | cancer | thyroid | RAS | RET ONCOGENE ACTIVATION | HYALINIZING TRABECULAR TUMORS | RAS POINT MUTATIONS | BRAF V600E MUTATION | PATHOLOGY | RET/PTC GENE REARRANGEMENTS | PAPILLARY CARCINOMAS | FINE-NEEDLE-ASPIRATION | BRAF(V600E) MUTATION | FOLLICULAR VARIANT | HIGH PREVALENCE | Paired Box Transcription Factors - genetics | Thyroid Neoplasms - diagnosis | Proto-Oncogene Proteins c-ret - metabolism | Prognosis | Receptors, G-Protein-Coupled - metabolism | Humans | Genetic Markers | Neoplasm Proteins - metabolism | PPAR gamma - metabolism | Oncogene Protein p21(ras) - metabolism | Thyroid Neoplasms - genetics | Molecular Diagnostic Techniques | Proto-Oncogene Proteins B-raf - genetics | Receptors, G-Protein-Coupled - genetics | Mutation | Neoplasm Proteins - genetics | PAX8 Transcription Factor | Paired Box Transcription Factors - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Oncogene Protein p21(ras) - genetics | PPAR gamma - genetics | Proto-Oncogene Proteins c-ret - genetics | Thyroid Neoplasms - metabolism
RET/PTC | BRAF | cancer | thyroid | RAS | RET ONCOGENE ACTIVATION | HYALINIZING TRABECULAR TUMORS | RAS POINT MUTATIONS | BRAF V600E MUTATION | PATHOLOGY | RET/PTC GENE REARRANGEMENTS | PAPILLARY CARCINOMAS | FINE-NEEDLE-ASPIRATION | BRAF(V600E) MUTATION | FOLLICULAR VARIANT | HIGH PREVALENCE | Paired Box Transcription Factors - genetics | Thyroid Neoplasms - diagnosis | Proto-Oncogene Proteins c-ret - metabolism | Prognosis | Receptors, G-Protein-Coupled - metabolism | Humans | Genetic Markers | Neoplasm Proteins - metabolism | PPAR gamma - metabolism | Oncogene Protein p21(ras) - metabolism | Thyroid Neoplasms - genetics | Molecular Diagnostic Techniques | Proto-Oncogene Proteins B-raf - genetics | Receptors, G-Protein-Coupled - genetics | Mutation | Neoplasm Proteins - genetics | PAX8 Transcription Factor | Paired Box Transcription Factors - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Oncogene Protein p21(ras) - genetics | PPAR gamma - genetics | Proto-Oncogene Proteins c-ret - genetics | Thyroid Neoplasms - metabolism
Journal Article
Dermatologic Clinics, ISSN 0733-8635, 10/2018, Volume 36, Issue 4, pp. 397 - 412
Cutaneous adnexal tumors include lesions with apocrine, eccrine, follicular, sebaceous, and mixed differentiation. Most are benign and sporadic, although...
Dermoscopy | Sebaceous tumors | Eccrine and apocrine tumors | Adnexal tumors | Follicular tumors | AMELANOTIC MELANOMA | DERMATOLOGY | INVERTED FOLLICULAR KERATOSIS | HOGG-DUBE SYNDROME | NEVUS SEBACEUS | BROOKE-SPIEGLER SYNDROME | EXTRAOCULAR SEBACEOUS CARCINOMA | BASAL-CELL CARCINOMA | SYRINGOCYSTADENOMA PAPILLIFERUM | PIGMENTED ECCRINE POROMA | SKIN TUMORS | Skin Neoplasms - diagnostic imaging | Acrospiroma - diagnostic imaging | Follicular Cyst - diagnostic imaging | Birt-Hogg-Dube Syndrome - diagnostic imaging | Humans | Carcinoma - diagnostic imaging | Sweat Gland Neoplasms - diagnostic imaging | Syringoma - diagnostic imaging | Tubular Sweat Gland Adenomas - diagnostic imaging | Neoplasms, Basal Cell - diagnostic imaging | Pilomatrixoma - diagnostic imaging | Nevus, Sebaceous of Jadassohn - diagnostic imaging | Hyperplasia - diagnostic imaging | Hidrocystoma - diagnostic imaging | Adenoma - diagnostic imaging | Carcinoma, Adenoid Cystic - diagnostic imaging | Neoplastic Syndromes, Hereditary - diagnostic imaging | Hair Diseases - diagnostic imaging | Poroma - diagnostic imaging | Sebaceous Gland Neoplasms - diagnostic imaging | Sebaceous Glands - pathology
Dermoscopy | Sebaceous tumors | Eccrine and apocrine tumors | Adnexal tumors | Follicular tumors | AMELANOTIC MELANOMA | DERMATOLOGY | INVERTED FOLLICULAR KERATOSIS | HOGG-DUBE SYNDROME | NEVUS SEBACEUS | BROOKE-SPIEGLER SYNDROME | EXTRAOCULAR SEBACEOUS CARCINOMA | BASAL-CELL CARCINOMA | SYRINGOCYSTADENOMA PAPILLIFERUM | PIGMENTED ECCRINE POROMA | SKIN TUMORS | Skin Neoplasms - diagnostic imaging | Acrospiroma - diagnostic imaging | Follicular Cyst - diagnostic imaging | Birt-Hogg-Dube Syndrome - diagnostic imaging | Humans | Carcinoma - diagnostic imaging | Sweat Gland Neoplasms - diagnostic imaging | Syringoma - diagnostic imaging | Tubular Sweat Gland Adenomas - diagnostic imaging | Neoplasms, Basal Cell - diagnostic imaging | Pilomatrixoma - diagnostic imaging | Nevus, Sebaceous of Jadassohn - diagnostic imaging | Hyperplasia - diagnostic imaging | Hidrocystoma - diagnostic imaging | Adenoma - diagnostic imaging | Carcinoma, Adenoid Cystic - diagnostic imaging | Neoplastic Syndromes, Hereditary - diagnostic imaging | Hair Diseases - diagnostic imaging | Poroma - diagnostic imaging | Sebaceous Gland Neoplasms - diagnostic imaging | Sebaceous Glands - pathology
Journal Article
Journal of Cell Science, ISSN 0021-9533, 12/2012, Volume 125, Issue 23, pp. 5591 - 5596
BREAST-CANCER | B-CELLS | IMMUNITY | ANGIOGENIC SWITCH | MACROPHAGES | MOUSE MODEL | REGULATORY T-CELLS | FOLLICULAR LYMPHOMA | SUPPRESSOR-CELLS | MYELOID CELLS | CELL BIOLOGY | T-Lymphocytes - metabolism | Humans | Extracellular Matrix - metabolism | Tumor Microenvironment | Killer Cells, Natural - metabolism | Neutrophils - metabolism | B-Lymphocytes - metabolism | Dendritic Cells - metabolism
Journal Article
Histopathology, ISSN 0309-0167, 07/2013, Volume 63, Issue 1, pp. 1 - 12
Aims To investigate t(14;18)/IGH–BCL2 in follicular lymphoma (FL) cases from Taiwan. Methods and results We retrospectively studied 93 consecutive cases, using...
BCL2 | t(14;18) | fluorescence in‐situ hybridization | follicular lymphoma | Taiwan | Follicular lymphoma | Fluorescence in-situ hybridization | T(14;18) | MALIGNANT-LYMPHOMA | EUROPEAN-AMERICAN CLASSIFICATION | 18 | IN-SITU HYBRIDIZATION | BCL2 GENE TRANSLOCATION | NON-HODGKINS-LYMPHOMAS | fluorescence in-situ hybridization | PATHOLOGY | CELL BIOLOGY | HEALTH-ORGANIZATION CLASSIFICATION | EMBEDDED TISSUE-SECTIONS | POLYMERASE-CHAIN-REACTION | INTERPHASE FISH | CLINICOPATHOLOGICAL ANALYSIS | Translocation, Genetic | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Gene Frequency | Humans | Middle Aged | Immunophenotyping | In Situ Hybridization, Fluorescence | Male | Lymphoma, Follicular - ethnology | Lymphoma, Follicular - genetics | Neoplasm Grading | Taiwan - epidemiology | Female | Retrospective Studies | Chromosomes, Human, Pair 18 - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Chromosomes, Human, Pair 14 - genetics | Immunohistochemistry | Fluorescence | Lymphomas | Tumors
BCL2 | t(14;18) | fluorescence in‐situ hybridization | follicular lymphoma | Taiwan | Follicular lymphoma | Fluorescence in-situ hybridization | T(14;18) | MALIGNANT-LYMPHOMA | EUROPEAN-AMERICAN CLASSIFICATION | 18 | IN-SITU HYBRIDIZATION | BCL2 GENE TRANSLOCATION | NON-HODGKINS-LYMPHOMAS | fluorescence in-situ hybridization | PATHOLOGY | CELL BIOLOGY | HEALTH-ORGANIZATION CLASSIFICATION | EMBEDDED TISSUE-SECTIONS | POLYMERASE-CHAIN-REACTION | INTERPHASE FISH | CLINICOPATHOLOGICAL ANALYSIS | Translocation, Genetic | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Gene Frequency | Humans | Middle Aged | Immunophenotyping | In Situ Hybridization, Fluorescence | Male | Lymphoma, Follicular - ethnology | Lymphoma, Follicular - genetics | Neoplasm Grading | Taiwan - epidemiology | Female | Retrospective Studies | Chromosomes, Human, Pair 18 - genetics | Lymphoma, Large B-Cell, Diffuse - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Chromosomes, Human, Pair 14 - genetics | Immunohistochemistry | Fluorescence | Lymphomas | Tumors
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 01/2013, Volume 98, Issue 1, pp. 308 - 313
Context: Chemokines are chemotactic cytokines responsible for the attraction and recruitment of different cell types during leukocyte infiltration, the...
ACTIVE GRAVES-DISEASE | CYTOKINES | THYROID FOLLICULAR CELLS | INDUCIBLE CHEMOKINES | OPHTHALMOPATHY | SERUM-LEVELS | ENDOCRINOLOGY & METABOLISM | RECEPTOR | METHIMAZOLE-THERAPY | EXPRESSION | MODULATION | Thyroid Neoplasms - diagnosis | Humans | Chemokine CXCL10 - physiology | Thyroid Neoplasms - complications | Interleukin-8 - physiology | Thyroiditis, Autoimmune - etiology | Signal Transduction - immunology | Carcinoma - complications | Inflammation Mediators - pharmacology | Thyroid Neoplasms - immunology | Thyroiditis, Autoimmune - metabolism | Inflammation Mediators - metabolism | Interleukin-8 - metabolism | Drug Evaluation, Preclinical | Thyroid Gland - cytology | Thyroid Gland - drug effects | Diagnosis, Differential | Carcinoma - immunology | Cells, Cultured | Carcinoma - diagnosis | Thyroiditis - etiology | Tumor Necrosis Factor-alpha - pharmacology | Signal Transduction - drug effects | Chemokines, CXC - metabolism | Thyroiditis, Autoimmune - diagnosis | Signal Transduction - physiology | Primary Cell Culture | Thyroiditis - diagnosis | Thyroid Gland - metabolism | Chemokine CXCL10 - metabolism | Interferon-gamma - pharmacology
ACTIVE GRAVES-DISEASE | CYTOKINES | THYROID FOLLICULAR CELLS | INDUCIBLE CHEMOKINES | OPHTHALMOPATHY | SERUM-LEVELS | ENDOCRINOLOGY & METABOLISM | RECEPTOR | METHIMAZOLE-THERAPY | EXPRESSION | MODULATION | Thyroid Neoplasms - diagnosis | Humans | Chemokine CXCL10 - physiology | Thyroid Neoplasms - complications | Interleukin-8 - physiology | Thyroiditis, Autoimmune - etiology | Signal Transduction - immunology | Carcinoma - complications | Inflammation Mediators - pharmacology | Thyroid Neoplasms - immunology | Thyroiditis, Autoimmune - metabolism | Inflammation Mediators - metabolism | Interleukin-8 - metabolism | Drug Evaluation, Preclinical | Thyroid Gland - cytology | Thyroid Gland - drug effects | Diagnosis, Differential | Carcinoma - immunology | Cells, Cultured | Carcinoma - diagnosis | Thyroiditis - etiology | Tumor Necrosis Factor-alpha - pharmacology | Signal Transduction - drug effects | Chemokines, CXC - metabolism | Thyroiditis, Autoimmune - diagnosis | Signal Transduction - physiology | Primary Cell Culture | Thyroiditis - diagnosis | Thyroid Gland - metabolism | Chemokine CXCL10 - metabolism | Interferon-gamma - pharmacology
Journal Article
Modern Pathology, ISSN 0893-3952, 04/2011, Volume 24, Issue S2, pp. S44 - S52
Systemic chemotherapies for advanced or metastatic thyroid carcinomas have been of only limited effectiveness. For patients with differentiated or medullary...
antineoplastic agents | thyroid carcinoma | angiogenesis inhibitors | protein kinase inihibitors | FACTOR VEGF | SOLID TUMORS | CANCER INCIDENCE | PATHOLOGY | ANTITUMOR-ACTIVITY | MULTIKINASE INHIBITOR | PHASE-II TRIAL | MEDULLARY | BRAF MUTATION | TYROSINE KINASE INHIBITOR | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma, Papillary - secondary | Clinical Trials, Phase III as Topic | Adenocarcinoma, Papillary - drug therapy | Thyroid Neoplasms - drug therapy | Adenocarcinoma, Follicular - secondary | Adenocarcinoma, Follicular - drug therapy | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy - methods | Randomized Controlled Trials as Topic | Thyroid Neoplasms - pathology
antineoplastic agents | thyroid carcinoma | angiogenesis inhibitors | protein kinase inihibitors | FACTOR VEGF | SOLID TUMORS | CANCER INCIDENCE | PATHOLOGY | ANTITUMOR-ACTIVITY | MULTIKINASE INHIBITOR | PHASE-II TRIAL | MEDULLARY | BRAF MUTATION | TYROSINE KINASE INHIBITOR | ENDOTHELIAL GROWTH-FACTOR | Adenocarcinoma, Papillary - secondary | Clinical Trials, Phase III as Topic | Adenocarcinoma, Papillary - drug therapy | Thyroid Neoplasms - drug therapy | Adenocarcinoma, Follicular - secondary | Adenocarcinoma, Follicular - drug therapy | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy - methods | Randomized Controlled Trials as Topic | Thyroid Neoplasms - pathology
Journal Article